The global market for Influenza A Vaccine was estimated to be worth US$ 7292 million in 2023 and is forecast to a readjusted size of US$ 11090 million by 2030 with a CAGR of 6.3% during the forecast period 2024-2030

Influenza A Vaccine - Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Influenza A Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Influenza A Vaccine by region & country, by Type, and by Application.

The Influenza A Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza A Vaccine.

Market Segmentation

Scope of Influenza A Vaccine - Market Report

Report Metric	Details
Report Name	Influenza A Vaccine - Market
Forecasted market size in 2030	US$ 11090 million
CAGR	6.3%
Forecasted years	2024 - 2030
Segment by Type:	Intramuscular Vaccine Nasal Spray Vaccine
Segment by Application	3-18 Years Old Above 18 Years Old
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Sanofi, GSK, Medimmune, Abbott, Mitsubishi Tanabe Pharma, Merck, Sinovac Biotech, Hualan Biological Engineering, Changsheng Bio-Technology, Beijing Tiantan Bio-Products
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Influenza A Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Influenza A Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Influenza A Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Influenza A Vaccine - Market size in 2030?

Ans: The Influenza A Vaccine - Market size in 2030 will be US$ 11090 million.

Who are the main players in the Influenza A Vaccine - Market report?

Ans: The main players in the Influenza A Vaccine - Market are Novartis, Sanofi, GSK, Medimmune, Abbott, Mitsubishi Tanabe Pharma, Merck, Sinovac Biotech, Hualan Biological Engineering, Changsheng Bio-Technology, Beijing Tiantan Bio-Products

What are the Application segmentation covered in the Influenza A Vaccine - Market report?

Ans: The Applications covered in the Influenza A Vaccine - Market report are 3-18 Years Old, Above 18 Years Old

What are the Type segmentation covered in the Influenza A Vaccine - Market report?

Ans: The Types covered in the Influenza A Vaccine - Market report are Intramuscular Vaccine, Nasal Spray Vaccine

1 Market Overview

1.1 Influenza A Vaccine Product Introduction

1.2 Global Influenza A Vaccine Market Size Forecast

1.2.1 Global Influenza A Vaccine Sales Value (2019-2030)

1.2.2 Global Influenza A Vaccine Sales Volume (2019-2030)

1.2.3 Global Influenza A Vaccine Sales Price (2019-2030)

1.3 Influenza A Vaccine Market Trends & Drivers

1.3.1 Influenza A Vaccine Industry Trends

1.3.2 Influenza A Vaccine Market Drivers & Opportunity

1.3.3 Influenza A Vaccine Market Challenges

1.3.4 Influenza A Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Influenza A Vaccine Players Revenue Ranking (2023)

2.2 Global Influenza A Vaccine Revenue by Company (2019-2024)

2.3 Global Influenza A Vaccine Players Sales Volume Ranking (2023)

2.4 Global Influenza A Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Influenza A Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Influenza A Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Influenza A Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Influenza A Vaccine

2.9 Influenza A Vaccine Market Competitive Analysis

2.9.1 Influenza A Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Influenza A Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza A Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Intramuscular Vaccine

3.1.2 Nasal Spray Vaccine

3.2 Global Influenza A Vaccine Sales Value by Type

3.2.1 Global Influenza A Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Influenza A Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Influenza A Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Influenza A Vaccine Sales Volume by Type

3.3.1 Global Influenza A Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Influenza A Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Influenza A Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Influenza A Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 3-18 Years Old

4.1.2 Above 18 Years Old

4.2 Global Influenza A Vaccine Sales Value by Application

4.2.1 Global Influenza A Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Influenza A Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Influenza A Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Influenza A Vaccine Sales Volume by Application

4.3.1 Global Influenza A Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Influenza A Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Influenza A Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Influenza A Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Influenza A Vaccine Sales Value by Region

5.1.1 Global Influenza A Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Influenza A Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Influenza A Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Influenza A Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Influenza A Vaccine Sales Volume by Region

5.2.1 Global Influenza A Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Influenza A Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Influenza A Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Influenza A Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Influenza A Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Influenza A Vaccine Sales Value, 2019-2030

5.4.2 North America Influenza A Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Influenza A Vaccine Sales Value, 2019-2030

5.5.2 Europe Influenza A Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Influenza A Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Influenza A Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Influenza A Vaccine Sales Value, 2019-2030

5.7.2 South America Influenza A Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Influenza A Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Influenza A Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Influenza A Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Influenza A Vaccine Sales Value

6.2.1 Key Countries/Regions Influenza A Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Influenza A Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Influenza A Vaccine Sales Value, 2019-2030

6.3.2 United States Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Influenza A Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Influenza A Vaccine Sales Value, 2019-2030

6.4.2 Europe Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Influenza A Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Influenza A Vaccine Sales Value, 2019-2030

6.5.2 China Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Influenza A Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Influenza A Vaccine Sales Value, 2019-2030

6.6.2 Japan Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Influenza A Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Influenza A Vaccine Sales Value, 2019-2030

6.7.2 South Korea Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Influenza A Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Influenza A Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Influenza A Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Influenza A Vaccine Sales Value, 2019-2030

6.9.2 India Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Influenza A Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Novartis

7.1.1 Novartis Company Information

7.1.2 Novartis Introduction and Business Overview

7.1.3 Novartis Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Novartis Influenza A Vaccine Product Offerings

7.1.5 Novartis Recent Development

7.2 Sanofi

7.2.1 Sanofi Company Information

7.2.2 Sanofi Introduction and Business Overview

7.2.3 Sanofi Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Sanofi Influenza A Vaccine Product Offerings

7.2.5 Sanofi Recent Development

7.3 GSK

7.3.1 GSK Company Information

7.3.2 GSK Introduction and Business Overview

7.3.3 GSK Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 GSK Influenza A Vaccine Product Offerings

7.3.5 GSK Recent Development

7.4 Medimmune

7.4.1 Medimmune Company Information

7.4.2 Medimmune Introduction and Business Overview

7.4.3 Medimmune Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Medimmune Influenza A Vaccine Product Offerings

7.4.5 Medimmune Recent Development

7.5 Abbott

7.5.1 Abbott Company Information

7.5.2 Abbott Introduction and Business Overview

7.5.3 Abbott Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Abbott Influenza A Vaccine Product Offerings

7.5.5 Abbott Recent Development

7.6 Mitsubishi Tanabe Pharma

7.6.1 Mitsubishi Tanabe Pharma Company Information

7.6.2 Mitsubishi Tanabe Pharma Introduction and Business Overview

7.6.3 Mitsubishi Tanabe Pharma Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Mitsubishi Tanabe Pharma Influenza A Vaccine Product Offerings

7.6.5 Mitsubishi Tanabe Pharma Recent Development

7.7 Merck

7.7.1 Merck Company Information

7.7.2 Merck Introduction and Business Overview

7.7.3 Merck Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Merck Influenza A Vaccine Product Offerings

7.7.5 Merck Recent Development

7.8 Sinovac Biotech

7.8.1 Sinovac Biotech Company Information

7.8.2 Sinovac Biotech Introduction and Business Overview

7.8.3 Sinovac Biotech Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Sinovac Biotech Influenza A Vaccine Product Offerings

7.8.5 Sinovac Biotech Recent Development

7.9 Hualan Biological Engineering

7.9.1 Hualan Biological Engineering Company Information

7.9.2 Hualan Biological Engineering Introduction and Business Overview

7.9.3 Hualan Biological Engineering Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Hualan Biological Engineering Influenza A Vaccine Product Offerings

7.9.5 Hualan Biological Engineering Recent Development

7.10 Changsheng Bio-Technology

7.10.1 Changsheng Bio-Technology Company Information

7.10.2 Changsheng Bio-Technology Introduction and Business Overview

7.10.3 Changsheng Bio-Technology Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.10.4 Changsheng Bio-Technology Influenza A Vaccine Product Offerings

7.10.5 Changsheng Bio-Technology Recent Development

7.11 Beijing Tiantan Bio-Products

7.11.1 Beijing Tiantan Bio-Products Company Information

7.11.2 Beijing Tiantan Bio-Products Introduction and Business Overview

7.11.3 Beijing Tiantan Bio-Products Influenza A Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Beijing Tiantan Bio-Products Influenza A Vaccine Product Offerings

7.11.5 Beijing Tiantan Bio-Products Recent Development

8 Industry Chain Analysis

8.1 Influenza A Vaccine Industrial Chain

8.2 Influenza A Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Influenza A Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Influenza A Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Changsheng Bio-Technology

Beijing Tiantan Bio-Products

Mitsubishi Tanabe Pharma

GSK

Sanofi

Novartis

Hualan Biological Engineering

List of Tables

Table 1. Influenza A Vaccine Market Trends

Table 2. Influenza A Vaccine Market Drivers & Opportunity

Table 3. Influenza A Vaccine Market Challenges

Table 4. Influenza A Vaccine Market Restraints

Table 5. Global Influenza A Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Influenza A Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Influenza A Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Influenza A Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Influenza A Vaccine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Influenza A Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Influenza A Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Influenza A Vaccine

Table 13. Global Influenza A Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Influenza A Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Influenza A Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Influenza A Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Influenza A Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Influenza A Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Influenza A Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Influenza A Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Influenza A Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Influenza A Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Influenza A Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Influenza A Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Influenza A Vaccine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Influenza A Vaccine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Influenza A Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Influenza A Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Influenza A Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Influenza A Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Influenza A Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Influenza A Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Influenza A Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Influenza A Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Influenza A Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Influenza A Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Influenza A Vaccine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Influenza A Vaccine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Influenza A Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Influenza A Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Influenza A Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Influenza A Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Influenza A Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Influenza A Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Influenza A Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Influenza A Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Influenza A Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Influenza A Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Influenza A Vaccine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Influenza A Vaccine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Influenza A Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Influenza A Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Influenza A Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Influenza A Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Influenza A Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. Novartis Company Information

Table 58. Novartis Introduction and Business Overview

Table 59. Novartis Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Novartis Influenza A Vaccine Product Offerings

Table 61. Novartis Recent Development

Table 62. Sanofi Company Information

Table 63. Sanofi Introduction and Business Overview

Table 64. Sanofi Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Sanofi Influenza A Vaccine Product Offerings

Table 66. Sanofi Recent Development

Table 67. GSK Company Information

Table 68. GSK Introduction and Business Overview

Table 69. GSK Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. GSK Influenza A Vaccine Product Offerings

Table 71. GSK Recent Development

Table 72. Medimmune Company Information

Table 73. Medimmune Introduction and Business Overview

Table 74. Medimmune Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Medimmune Influenza A Vaccine Product Offerings

Table 76. Medimmune Recent Development

Table 77. Abbott Company Information

Table 78. Abbott Introduction and Business Overview

Table 79. Abbott Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Abbott Influenza A Vaccine Product Offerings

Table 81. Abbott Recent Development

Table 82. Mitsubishi Tanabe Pharma Company Information

Table 83. Mitsubishi Tanabe Pharma Introduction and Business Overview

Table 84. Mitsubishi Tanabe Pharma Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Mitsubishi Tanabe Pharma Influenza A Vaccine Product Offerings

Table 86. Mitsubishi Tanabe Pharma Recent Development

Table 87. Merck Company Information

Table 88. Merck Introduction and Business Overview

Table 89. Merck Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Merck Influenza A Vaccine Product Offerings

Table 91. Merck Recent Development

Table 92. Sinovac Biotech Company Information

Table 93. Sinovac Biotech Introduction and Business Overview

Table 94. Sinovac Biotech Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Sinovac Biotech Influenza A Vaccine Product Offerings

Table 96. Sinovac Biotech Recent Development

Table 97. Hualan Biological Engineering Company Information

Table 98. Hualan Biological Engineering Introduction and Business Overview

Table 99. Hualan Biological Engineering Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. Hualan Biological Engineering Influenza A Vaccine Product Offerings

Table 101. Hualan Biological Engineering Recent Development

Table 102. Changsheng Bio-Technology Company Information

Table 103. Changsheng Bio-Technology Introduction and Business Overview

Table 104. Changsheng Bio-Technology Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. Changsheng Bio-Technology Influenza A Vaccine Product Offerings

Table 106. Changsheng Bio-Technology Recent Development

Table 107. Beijing Tiantan Bio-Products Company Information

Table 108. Beijing Tiantan Bio-Products Introduction and Business Overview

Table 109. Beijing Tiantan Bio-Products Influenza A Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Beijing Tiantan Bio-Products Influenza A Vaccine Product Offerings

Table 111. Beijing Tiantan Bio-Products Recent Development

Table 112. Key Raw Materials Lists

Table 113. Raw Materials Key Suppliers Lists

Table 114. Influenza A Vaccine Downstream Customers

Table 115. Influenza A Vaccine Distributors List

Table 116. Research Programs/Design for This Report

Table 117. Key Data Information from Secondary Sources

Table 118. Key Data Information from Primary Sources

List of Figures

Figure 1. Influenza A Vaccine Product Picture

Figure 2. Global Influenza A Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Influenza A Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Influenza A Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Influenza A Vaccine Sales Price (2019-2030) & (US$/Unit)

Figure 6. Influenza A Vaccine Report Years Considered

Figure 7. Global Influenza A Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Influenza A Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Influenza A Vaccine Revenue in 2023

Figure 10. Influenza A Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Intramuscular Vaccine Picture

Figure 12. Nasal Spray Vaccine Picture

Figure 13. Global Influenza A Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Influenza A Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Influenza A Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Influenza A Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Influenza A Vaccine Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of 3-18 Years Old

Figure 19. Product Picture of Above 18 Years Old

Figure 20. Global Influenza A Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Influenza A Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Influenza A Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Influenza A Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Influenza A Vaccine Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Influenza A Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Influenza A Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Influenza A Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Influenza A Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Influenza A Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Influenza A Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Influenza A Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Influenza A Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Influenza A Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Influenza A Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Influenza A Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Influenza A Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Influenza A Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Influenza A Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Influenza A Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Influenza A Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Influenza A Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Influenza A Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Influenza A Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Influenza A Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Influenza A Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Influenza A Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Influenza A Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Influenza A Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Influenza A Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Influenza A Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Influenza A Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Influenza A Vaccine Industrial Chain

Figure 59. Influenza A Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions